November 13, 2023 Bariatric Medicine Obesity drug Wegovy cut risk of serious heart problems by 20 per cent, study finds
December 19, 2022 Bariatric Medicine Meta-analyses of randomized controlled trials looks at efficacy of semaglutide (Ozempic) in treating people suffering with obesity
December 15, 2022 Bariatric Medicine Diabetes drug in short supply in U.S. (but not in Canada) after celebrities, influencers touted its weight-loss benefits.
June 8, 2022 Bariatric Medicine Wegovy (semaglutide) approved by FDA to support people struggling to lose weight (and that includes many). Health Canada did so in November 2021. Major addition to weight-loss management options.
May 11, 2022 Bariatric Medicine Treatments for weight loss do exist, work well for many, and reveal our growing understanding of how our homeostatic, motivational, and executive brain centers interact with respect to weight control.
November 14, 2021 Bariatric Medicine Sunday House Call, #815, November 14, 2021: @YoniFreedhoff discusses “2021’s dumbest scientifically published exercise recommendation for the treatment of obesity” and what works in reality.
June 6, 2021 Sunday House Call Shows A step forward for management of obesity with approval of semaglutide by FDA. @YoniFreedhoff joins me to discuss fat shaming, weight bias and how we need to turn this around and help those suffering with obesity as we would with any other chronic disease.
February 16, 2021 Bariatric Medicine NEJM publishes study evaluating the use of semaglutide to assist people with weight loss. Not “game-changing” but another positive step forward for evidenced-based treatment to help people with #Overweight or #Obesity.
February 14, 2021 Bariatric Medicine Not “game-changing” but another positive step forward for evidenced-based treatment to help people with #Overweight or #Obesity.